TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.

Zobair M Younossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.